You are completely right. The share price seems sensible at the moment according to my price multiple model, where I compare the company’s price-to-earnings ratio to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 8.67x is currently trading slightly below its industry peers’ ratio of 12.41x, which means if you buy Capitol Health today, you’d be paying a decent price for it.
Lifesaver capital raising, page-33
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $261.1M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $162.8K | 660.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 77807 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 41976 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
0.000 ( 2.08 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 25.0¢ | 24.5¢ | 104857 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CAJ (ASX) Chart |